SCHEMBL10239803

SCHEMBL10239803

CC1(COc2ccc(Nc3cncc(Cl)n3)c(N(O)O)c2)COC1

nearest known ligand 0.36

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 2/20 0.36
CHEK2 O96017 1/20 0.36
AKT1 P31749 1/20 0.36
PDE2A O00408 1/20 0.36
PDE10A Q9Y233 1/20 0.36
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
CACNA1H O95180 5/20 0.35
ACACB O00763 1/20 0.35
FLT3 P36888 7/20 0.35
BACE1 P56817 1/20 0.34
SYK P43405 2/20 0.34
CACNA1G O43497 1/20 0.33
CACNA1I Q9P0X4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL376772 0.85 BACE1 (0.39) CHEK1CHEK2AKT1PDE2APDE10A
SCHEMBL376452 0.81 MAPT (0.38) CHEK1CHEK2AKT1PDE2APDE10A
SCHEMBL375935 0.67 FLT3 (0.53) PDE2APDE10AFLT3BACE1
SCHEMBL30764823 0.65 PDE2A (0.41) PDE2APDE10AFLT3
SCHEMBL21617085 0.65 PDE2A (0.41) PDE2APDE10AFLT3
SCHEMBL9935890 0.64 ACACB (0.50) PDE2APDE10ACACNA1HACACBFLT3
SCHEMBL21447017 0.64 ACACB (0.43) CHEK1CHEK2AKT1PDE2APDE10A
SCHEMBL15985609 0.63 PDE2A (0.47) CHEK1CHEK2AKT1PDE2APDE10A
SCHEMBL7187755 0.63 AGXT (0.47) PDE2APDE10ANPC1RAB9AACACB
SCHEMBL10283407 0.63 PDE2A (0.42) CHEK1CHEK2AKT1PDE2APDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2328890-B1 6 SUBSTITUTED 2-HETEROCYCLYLAMINO PYRAZINE COMPOUNDS AS CHK-1 INHIBITORS PFIZER (US) 2012-01-25 EP disclosed
WO-2010016005-A1 6 SUBSTITUTED 2-HETEROCYCLYLAMINO PYRAZINE COMPOUNDS AS CHK-1 INHIBITORS PFIZER INC. (US) 2010-02-11 WO disclosed